Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro Diagnostics

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1737413

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1737413

Skin Biopsy

PUBLISHED:
PAGES: 370 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Skin Biopsy Market to Reach US$149.2 Million by 2030

The global market for Skin Biopsy estimated at US$116.9 Million in the year 2024, is expected to reach US$149.2 Million by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Shave Biopsy, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$75.4 Million by the end of the analysis period. Growth in the Punch Biopsy segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$31.9 Million While China is Forecast to Grow at 7.4% CAGR

The Skin Biopsy market in the U.S. is estimated at US$31.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$30.2 Million by the year 2030 trailing a CAGR of 7.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR.

Global "Skin Biopsy" Market - Key Trends & Drivers Summarized

Why Has Skin Biopsy Become The Diagnostic Cornerstone Of Dermatological Care?

Skin biopsy has solidified its position as a primary diagnostic technique in modern dermatology, offering critical insights into a wide range of skin conditions, from benign growths and inflammatory disorders to autoimmune diseases and various forms of skin cancer. Performed using methods such as shave biopsy, punch biopsy, excisional biopsy, or incisional biopsy, the procedure allows for the extraction and histopathological analysis of skin tissue. It is minimally invasive, quick, and can be done in outpatient settings, making it a practical and accessible tool for clinicians. The rising global incidence of skin cancers-especially melanoma, basal cell carcinoma, and squamous cell carcinoma-has made early and accurate biopsy-driven diagnosis a medical necessity. Additionally, chronic dermatological conditions like psoriasis, eczema, lupus erythematosus, and lichen planus often require biopsy confirmation to tailor treatment. In the age of precision medicine, biopsies are not only diagnostic but also prognostic, enabling biomarker discovery, genetic analysis, and immunohistochemical profiling. Infections like fungal dermatoses, leprosy, and cutaneous tuberculosis also necessitate skin biopsies in endemic regions. With their utility spanning across disease types, age groups, and healthcare environments, skin biopsies are indispensable for timely, definitive dermatological diagnosis and treatment planning.

How Are Technological Advances Enhancing Accuracy And Efficiency In Skin Biopsy Procedures?

Recent technological innovations are transforming skin biopsy from a manual, visually guided procedure into a data-rich diagnostic process. High-resolution dermoscopy and digital imaging systems now allow dermatologists to identify suspicious lesions with greater precision before a biopsy is performed. Robotics-assisted punch biopsy tools and microtome-integrated skin scanners are improving procedural consistency and reducing tissue damage. Histopathology workflows have also been upgraded through digital pathology platforms that use AI and machine learning to scan, classify, and interpret tissue samples with enhanced accuracy and speed. Whole-slide imaging, coupled with cloud-based data sharing, allows for remote consultations and second opinions in complex cases. Meanwhile, minimally invasive techniques such as adhesive patch biopsies (e.g., tape stripping) are gaining attention for their ability to collect superficial cells painlessly, especially in pediatric and cosmetic dermatology. Molecular diagnostic assays and genomic sequencing are now routinely conducted on biopsy samples, revealing mutations and immune signatures that inform personalized treatment-especially in melanomas and rare cutaneous lymphomas. Automation in biopsy kits, including single-use sterilized instruments, built-in anesthetics, and rapid fixation solutions, is streamlining in-clinic procedures. Together, these advancements are not only enhancing diagnostic yield but also improving patient safety, satisfaction, and outcomes.

Where Is Skin Biopsy Playing A Transformative Role Across Clinical And Public Health Sectors?

Skin biopsy is playing a pivotal role across dermatology clinics, oncology centers, pathology labs, academic institutions, and public health programs worldwide. In developed healthcare systems, biopsies are integral to dermatopathology workflows, guiding treatment decisions in skin cancers and autoimmune conditions. In oncology, biopsies are essential for staging tumors, evaluating surgical margins, and assessing treatment response. In immunodermatology, they support the diagnosis of complex blistering diseases, vasculitis, and connective tissue disorders. Pediatric dermatologists rely on biopsies to distinguish between benign pediatric rashes and early-onset genetic syndromes. In underserved and remote areas, mobile dermatology units equipped with biopsy kits are helping screen and diagnose neglected tropical diseases, including leishmaniasis and mycetoma. Public skin cancer screening campaigns often integrate biopsy capabilities to provide same-day diagnosis and triage. Biopsies also play a critical role in clinical trials for new dermatological therapies, serving as baseline and post-treatment benchmarks for efficacy. Furthermore, skin biopsies are foundational in academic and pharmaceutical research, aiding in the development of new biologics, topical treatments, and vaccines. Their cross-disciplinary importance-from early detection to precision oncology and therapeutic research-highlights their indispensable role in modern healthcare ecosystems.

The Growth In The Skin Biopsy Market Is Driven By Several Factors That Reflect Dermatological Disease Trends, Technological Integration, And Healthcare Accessibility Expansion

A significant growth driver is the global rise in skin cancer incidence, especially melanoma, driven by aging populations, increased UV exposure, and lifestyle changes. Parallel growth in dermatology services, driven by improved awareness and proactive skin health behaviors, has led to a higher volume of skin biopsies in both clinical and cosmetic settings. Technological integration-particularly digital pathology, AI-assisted diagnostics, and molecular analysis-has expanded the scope and efficiency of biopsy utility, encouraging broader adoption across healthcare tiers. Additionally, the growing availability of dermatology services in ambulatory and outpatient settings has made biopsies more accessible, fueling procedural growth even outside of hospitals. The surge in autoimmune and inflammatory skin disorders, especially among younger demographics and due to environmental stressors, further amplifies the need for histopathological confirmation. Increasing healthcare spending and infrastructure in emerging economies, combined with efforts to reduce the burden of undiagnosed cancers and neglected skin conditions, are driving market growth in Asia-Pacific, Latin America, and Africa. Meanwhile, regulatory approval of newer biopsy tools and non-invasive sampling techniques is diversifying product portfolios and reducing procedural barriers. These intersecting trends-disease prevalence, diagnostic innovation, healthcare decentralization, and global access-are powering the strong, sustained expansion of the skin biopsy market.

SCOPE OF STUDY:

The report analyzes the Skin Biopsy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Shave Biopsy, Punch Biopsy, Excisional Biopsy); Indication (Skin Cancer, Actinic Keratosis, Dermatitis, Other Indications); End-Use (Hospitals & Clinics, Diagnostic Laboratories, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • AccuTec Blades Inc.
  • Acuderm Inc.
  • Becton, Dickinson and Company
  • Biodesix
  • Biomarker Technologies
  • Boston Scientific Corporation
  • Cardinal Health
  • Cook Medical
  • Danaher Corporation
  • DTR Medical Ltd
  • Exact Sciences Corporation
  • Freenome Holdings, Inc.
  • Gallini Srl
  • GenMark Diagnostics
  • GRAIL, Inc.
  • Hologic, Inc.
  • Innovia Medical
  • Integra LifeSciences
  • Leica Biosystems
  • Vernacare

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

Show more
Product Code: MCP34342

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Skin Biopsy - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Skin Cancer and Chronic Dermatological Conditions Drives Biopsy Demand
    • Growing Awareness and Early Diagnosis Campaigns Propel Skin Biopsy Procedure Volume
    • Advancements in Minimally Invasive Biopsy Devices Improve Patient Acceptance and Outcomes
    • Increased Adoption of Teledermatology and AI Diagnostics Strengthens Screening Rates
    • Integration of Biopsy Services into Primary Care Clinics Expands Patient Access
    • Dermatology-Focused Clinical Trials and R&D Stimulate Market for Diagnostic Biopsies
    • Regulatory Approvals for New Biopsy Tools Accelerate Technology Penetration
    • Rising Demand for Histopathological Analysis in Aesthetic Dermatology Expands Market Scope
    • Expansion of Skin Biopsy Use in Personalized Medicine Drives Precision Diagnostics
    • Aging Population with Higher Incidence of Skin Disorders Sustains Long-Term Demand
    • Rapid Growth in Outpatient Dermatology Centers Spurs Procedural Volume
    • Health Insurance Coverage Expansion in Emerging Markets Improves Accessibility to Biopsy Services
    • Technological Improvements in Imaging-Guided Biopsies Enhance Diagnostic Accuracy
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Skin Biopsy Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Skin Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Skin Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Skin Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Shave Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Shave Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Shave Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Punch Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Punch Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Punch Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Excisional Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Excisional Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Excisional Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Skin Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Skin Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Skin Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Actinic Keratosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Actinic Keratosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Actinic Keratosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Dermatitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Dermatitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Dermatitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
  • JAPAN
    • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
  • CHINA
    • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
  • EUROPE
    • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Skin Biopsy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Skin Biopsy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Skin Biopsy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
  • FRANCE
    • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
  • GERMANY
    • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Skin Biopsy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Skin Biopsy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Skin Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
  • INDIA
    • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Skin Biopsy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Skin Biopsy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Skin Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Skin Biopsy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Skin Biopsy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Skin Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
  • AFRICA
    • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!